Biogen Inc (BIIB) Stock Forecast & Predictions

Biogen Inc BIIB: $371.9

225 Binney St, Cambridge, Massachusetts, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: www.biogen.com

  • Market Cap$56.37B
  • Change (52 Weeks)39.60%
  • Low (52 Weeks)$223.25
  • Biogen Inc (BIIB) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 25.00% are on Buy, 31.25% on Sell, and 43.75% Neutral.

    According to the market data, Biogen Inc (BIIB) stock price is $371.9 and the 52 weeks low is $223.25, which means the Biogen Inc stock price is up 39.60% in the last 12 months.

    Biogen Inc (BIIB) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 25.00% are indicating that BIIB Stock price might rise further, 31.25% indicating that BIIB Stock price might fall, and 43.75% are in a neutral position.

    Based on these technical algorithms, overall BIIB stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Biogen Inc (BIIB) Stock Forecast By Analysts


    On Hold
    Analysts Recommendations for Biogen Inc (BIIB) is based on 39 Institutional Analyst Ratings where 17.95% are on Strong Buy, 20.51% on Moderate Buy, 46.15% remains on Hold, 5.13% are on Moderate Sell and 10.26% are on Strong Sell.

    Out of 39 Institutional Analysts, majority recommended BIIB stock as On Hold. This means investors are recommended to hold their existing positions if any, otherwise, the recommendation is neither to buy nor sell at this stage. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Biogen Inc.

    Biogen Inc (BIIB) Stock Price Prediction By Analysts


    HighLowAverage
    $679.35$246.44$413.52
    $413.5211.19% Upside
    Updated: 2021-06-18 00:00:00

    The Average Price target for BIIB set by the institutional analysts is $413.52 where High Estimate is $679.35, Median $423.3 and Low $246.44.

    The average price target for BIIB by Institutional Analysts is $413.52, which is 11.19% Upside from the current price. So according to the Institutional Analysts, BIIB Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Biogen Inc (BIIB) Stock Forecast Based on Investor Sentiment


    Very Positive

    Based on 434,839 investor portfolio.

    Our algorithm has analysed 434,839 investor portfolio with BIIB stock holdings and found that 99.50% of them are bullish. Which means the Investor Sentiment is mostly Very Positive.

    This shows most investors are very optimistic about BIIB and holding their positions hoping for a further rise in the stock price and more profit.

    Biogen Inc (BIIB) Stock Forecast Based on News Sentiment


    Bullish
    Based on 47 articles published Last Week, where 80.00% are Bullish and 20.00% are Bearish.

    According to the news articles published last week, most journalists and bloggers talked positively about BIIB, it shows that Biogen Inc had a 80.00% positive news coverage.

    Positive news coverage usually affects short-term price of a stock, so this positive coverage provides an indication that BIIB stock price may surge in the next few weeks.

    Biogen Inc (BIIB) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Piper SandlerOverweightUpgraded
    Truist SecuritiesBuyMaintained
    Goldman SachsNeutralMaintained
    BernsteinOutperformUpgraded
    UBSBuyUpgraded
    SVB LeerinkOutperformMaintained
    William BlairOutperformUpgraded
    RBC CapitalSector PerformMaintained
    Morgan StanleyOverweightMaintained
    JefferiesBuyMaintained
    HC Wainwright & Co.BuyMaintained
    CitigroupNeutralUpgraded
    BarclaysEqual-WeightMaintained
    BairdNeutralUpgraded
    OppenheimerOutperformMaintained
    Morgan StanleyOverweightMaintained
    WedbushNeutralMaintained
    Cantor FitzgeraldNeutralMaintained
    SVB LeerinkOutperformMaintained
    Morgan StanleyOverweightMaintained
    HC Wainwright & Co.BuyMaintained
    Credit SuisseOutperformMaintained
    Morgan StanleyOverweightMaintained
    RBC CapitalSector PerformMaintained
    DZ BankBuyUpgraded
    SVB LeerinkOutperformMaintained
    HC Wainwright & Co.BuyMaintained
    Cowen & Co.Market PerformDowngraded
    B of A SecuritiesUnderperformDowngraded
    Atlantic EquitiesUnderweightDowngraded
    SVB LeerinkOutperformMaintained
    BMO CapitalMarket PerformMaintained
    B of A SecuritiesNeutralUpgraded
    UBSNeutralInitiated
    MizuhoNeutralMaintained
    WedbushNeutralMaintained
    Morgan StanleyOverweightMaintained
    Credit SuisseOutperformMaintained
    Piper SandlerNeutralMaintained
    B of A SecuritiesUnderperformMaintained
    Morgan StanleyOverweightMaintained
    RBC CapitalSector PerformMaintained
    SVB LeerinkOutperformMaintained
    Morgan StanleyOverweightUpgraded
    Morgan StanleyUnderweightMaintained
    RBC CapitalSector PerformMaintained
    BarclaysEqual-WeightDowngraded
    BairdUnderperformMaintained
    BernsteinMarket PerformDowngraded
    Cantor FitzgeraldNeutralReiterated
    Canaccord GenuityBuyMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Raymond JamesUnderperformDowngraded
    OppenheimerOutperformMaintained
    Morgan StanleyUnderweightMaintained
    Credit SuisseNeutralMaintained
    CitigroupSellDowngraded
    BarclaysOverweightMaintained
    BarclaysOverweightInitiated
    MizuhoNeutralMaintained
    NomuraBuyMaintained
    Wells FargoEqual-WeightMaintained
    SVB LeerinkOutperformMaintained
    Morgan StanleyUnderweightMaintained
    Credit SuisseNeutralMaintained
    Cantor FitzgeraldNeutralReiterated
    BairdUnderperformMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Morgan StanleyUnderweightMaintained
    Canaccord GenuityBuyUpgraded
    Morgan StanleyUnderweightMaintained
    Credit SuisseNeutralUpgraded
    BairdUnderperformDowngraded
    SunTrust Robinson HumphreyBuyInitiated
    Standpoint ResearchHoldDowngraded
    BernsteinOutperformUpgraded
    SVB LeerinkOutperformUpgraded
    Morgan StanleyUnderweightMaintained
    JP MorganNeutralMaintained
    H.C. WainwrightBuyReiterated
    GuggenheimBuyUpgraded
    Credit SuisseUnderperformMaintained
    Cowen & Co.OutperformMaintained
    Canaccord GenuityHoldMaintained
    BMO CapitalMarket PerformMaintained
    Morgan StanleyUnderweightMaintained
    Canaccord GenuityHoldMaintained
    Piper JaffrayNeutralDowngraded
    WedbushNeutralInitiated
    Credit SuisseUnderperformInitiated
    BarclaysEqual-WeightMaintained
    UBSNeutralDowngraded
    NomuraBuyMaintained
    Morgan StanleyUnderweightDowngraded
    MizuhoNeutralDowngraded
    CitigroupNeutralDowngraded
    Canaccord GenuityHoldDowngraded
    William BlairMarket PerformDowngraded
    Cantor FitzgeraldNeutralDowngraded
    Atlantic EquitiesNeutralDowngraded
    GuggenheimNeutralDowngraded
    BMO CapitalMarket PerformInitiated
    Stifel NicolausHoldDowngraded
    BTIG ResearchBuyInitiated
    Morgan StanleyOverweightMaintained
    JP MorganOverweightMaintained
    BernsteinMarket PerformDowngraded
    UBSBuyMaintained
    Morgan StanleyOverweightMaintained
    BarclaysEqual-WeightMaintained
    BairdNeutralMaintained
    Canaccord GenuityBuyMaintained
    Morgan StanleyOverweightMaintained
    BairdNeutralDowngraded
    CitigroupBuyUpgraded
    Canaccord GenuityBuyUpgraded
    CitigroupNeutralMaintained
    Morgan StanleyOverweightMaintained
    BairdOutperformUpgraded
    BarclaysEqual-WeightDowngraded
    BMO CapitalOutperformMaintained
    ArgusHoldDowngraded
    MizuhoBuyMaintained
    UBSBuyUpgraded
    OppenheimerOutperformMaintained
    H.C. WainwrightBuyMaintained
    Canaccord GenuityHoldMaintained
    OppenheimerOutperformInitiated
    BMO CapitalOutperformMaintained
    Canaccord GenuityHoldInitiated
    UBSNeutralMaintained
    BMO CapitalOutperformUpgraded
    GuggenheimBuyInitiated
    CitigroupNeutralDowngraded
    Bank of AmericaBuyMaintained
    Stifel NicolausBuyUpgraded
    MizuhoBuyUpgraded
    Morgan StanleyOverweightUpgraded
    Raymond JamesMarket PerformDowngraded
    SunTrust Robinson HumphreyBuyInitiated
    RBC CapitalSector PerformInitiated
    BMO CapitalMarket PerformMaintained
    Goldman SachsConviction BuyUpgraded
    UBSNeutralMaintained
    Morgan StanleyEqual-WeightMaintained
    Goldman SachsBuyUpgraded
    BMO CapitalMarket PerformMaintained
    Morgan StanleyEqual-WeightMaintained
    Deutsche BankBuyInitiated
    UBSNeutralUpgraded
    Morgan StanleyEqual-WeightDowngraded
    Leerink SwannMarket PerformDowngraded
    CitigroupBuyUpgraded
    CitigroupBuyUpgraded
    Cantor FitzgeraldNeutralInitiated
    MizuhoNeutralInitiated
    PiperJaffrayOverweightUpgraded
    Leerink SwannOutperformUpgraded
    JefferiesHoldMaintained
    JefferiesHoldDowngraded
    Morgan StanleyOverweightMaintained
    Standpoint ResearchHoldDowngraded
    Raymond JamesStrong BuyMaintained
    Morgan StanleyOverweightMaintained
    BernsteinOutperformInitiated
    CitigroupBuyMaintained
    CitigroupNeutralDowngraded
    Goldman SachsNeutralMaintained
    BMO CapitalMarket PerformInitiated
    BairdNeutralMaintained
    CitigroupBuyInitiated
    Leerink SwannMarket PerformInitiated
    JefferiesBuyMaintained
    Credit SuisseNeutralInitiated
    Standpoint ResearchBuyInitiated
    Atlantic EquitiesOverweightInitiated
    PiperJaffrayOverweightUpgraded
    JefferiesBuyMaintained
    Leerink SwannOutperformMaintained
    JefferiesBuyInitiated
    H.C. WainwrightBuyInitiated
    Morgan StanleyOverweightMaintained
    BernsteinOutperformUpgraded
    BairdNeutralDowngraded
    PiperJaffrayNeutralDowngraded
    Bank of AmericaBuyUpgraded
    Leerink SwannOutperformMaintained
    Leerink SwannOutperformMaintained
    NomuraNeutralMaintained
    CitigroupBuyMaintained
    BMO CapitalOutperformMaintained
    Stifel NicolausHoldDowngraded
    CitigroupBuyMaintained
    Leerink SwannOutperformMaintained
    Stifel NicolausBuyMaintained
    CitigroupBuyMaintained
    BarclaysOverweightMaintained
    BarclaysOverweightInitiated
    NomuraNeutralDowngraded
    Credit SuisseOutperformMaintained
    CitigroupBuyMaintained
    BairdOutperformUpgraded
    UBSNeutralMaintained
    NomuraBuyMaintained
    JefferiesBuyMaintained
    Deutsche BankBuyMaintained
    Credit SuisseOutperformMaintained
    JP MorganOverweightUpgraded
    JefferiesBuyMaintained
    NomuraBuyMaintained
    Morgan StanleyOverweightInitiated
    Stifel NicolausBuyMaintained
    BarclaysOverweightMaintained
    BMO CapitalOutperformUpgraded
    Credit SuisseOutperformMaintained
    Deutsche BankBuyMaintained
    Stifel NicolausBuyMaintained
    NomuraBuyInitiated
    CitigroupBuyMaintained
    Deutsche BankBuyMaintained
    Credit SuisseOutperformMaintained
    CitigroupBuyMaintained
    FBR CapitalOutperformMaintained
    BMO CapitalMarket PerformMaintained
    CitigroupBuyUpgraded
    CitigroupNeutralDowngraded
    Deutsche BankBuyMaintained
    CitigroupBuyMaintained
    UBSNeutralMaintained
    Bank of AmericaBuyUpgraded
    RBC CapitalOutperformMaintained
    Credit SuisseOutperformMaintained
    Stifel NicolausBuyMaintained
    JMP SecuritiesMarket OutperformInitiated
    JefferiesBuyMaintained
    Goldman SachsBuyMaintained
    Canaccord GenuityBuyMaintained
    Bank of AmericaNeutralMaintained
    Morgan StanleyOverweightMaintained
    Bank of AmericaNeutralMaintained
    Credit SuisseOutperformMaintained
    Canaccord GenuityBuyUpgraded
    Credit SuisseOutperformMaintained
    CitigroupBuyUpgraded
    JefferiesBuyMaintained
    Deutsche BankBuyMaintained
    UBSNeutralMaintained
    JefferiesBuyMaintained
    PiperJaffrayNeutralDowngraded
    OppenheimerPerformMaintained
    Canaccord GenuityHoldMaintained
    Bank of AmericaBuyMaintained
    Canaccord GenuityHoldInitiated
    Brean CapitalBuyInitiated
    BMO CapitalMarket PerformMaintained
    PiperJaffrayOverweightMaintained
    BarclaysOverweightMaintained
    Credit SuisseOutperformMaintained
    OppenheimerPerformDowngraded
    Stifel NicolausBuyMaintained
    JefferiesBuyMaintained
    Bank of AmericaBuyMaintained
    UBSNeutralDowngraded
    Deutsche BankBuyMaintained
    UBSBuyMaintained
    Morgan StanleyOverweightMaintained
    JefferiesBuyMaintained
    CitigroupNeutralMaintained
    Stifel NicolausBuyMaintained
    UBSBuyMaintained
    JefferiesBuyMaintained
    PiperJaffrayOverweightMaintained
    OppenheimerOutperformMaintained
    CitigroupNeutralMaintained
    OppenheimerOutperformMaintained
    Goldman SachsBuyUpgraded
    Morgan StanleyOverweightInitiated

    Biogen Inc (BIIB) Stock Earning Per Share (EPS) Forecast / Estimate


    $4.680
    The average consensus EPS for BIIB is $4.680 with a high estimate of $6.226 and Low of $3.802 for the period 2021-09-30 and based on 29 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $5.34$5.1440642021-03-31


    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $$4.74415260000000052021-06-30
    $5.34$5.1440642021-03-31
    $4.58$4.9672982020-12-31
    $8.84$8.2004942020-09-30
    $10.26$8.1931500000000012020-06-30
    $9.14$7.887152020-03-31
    $8.34$8.1822360000000012019-12-31
    $9.17$8.4368282019-09-30
    $9.15$7.6803962019-06-30
    $6.98$7.00342200000000052019-03-31
    $6.99$6.868172018-12-31
    $7.4$6.9199862018-09-30
    $5.8$5.3125680000000012018-06-30
    $6.05$6.0555362018-03-31
    $5.26$5.5592039999999992017-12-31
    $6.31$5.83952017-09-30
    $5.04$4.497182017-06-30
    $5.2$5.069912017-03-31
    $5.04$5.0635862016-12-31
    $5.19$5.0650142016-09-30
    $5.21$4.76342016-06-30
    $4.79$4.5612362016-03-31
    $4.5$4.1603762015-12-31
    $4.48$3.878552015-09-30
    $4.22$4.183022015-06-30
    $3.82$3.992282015-03-31
    $4.09$3.85052014-12-31
    $3.8$3.526652014-09-30
    $3.34$2.88476399999999972014-06-30
    $2.47$2.6057942014-03-31
    $2.34$2.32478399999999972013-12-31
    $2.35$2.1464882013-09-30
    $2.3$1.97002800000000012013-06-30
    $1.97$1.6455662013-03-31
    $1.4$1.48797600000000022012-12-31
    $1.91$1.6349582012-09-30
    $1.82$1.5953822012-06-30
    $1.4$1.5100082012-03-31
    $1.51$1.51653599999999992011-12-31
    $1.61$1.5567242011-09-30

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).